- 期刊
- OpenAccess
Liver Enzymes and its Correlates in Treated and Newly Diagnosed Type 2 Diabetes Mellitus Patients in Osogbo, South West, Nigeria
並列摘要
Previous studies suggested that alteration in liver enzymes may be a predisposing and probable risk factor of Type 2 Diabetes Mellitus (T2DM) and complication of long standing T2DM. The aim of this study was to evaluate the prevalence of elevated liver enzymes in T2DM on treatment and the newly diagnosed in a Nigerian population and the relationship between the duration of the T2DM and the levels of the enzymes. A total of 117 subjects comprising 52 and 25 T2DM on treatment and newly diagnosed respectively; and 40 controls were recruited. Ten milliliter of blood were collected from antecubital vein of the subjects for analysis. There was no significant difference in the level of gamma-glutamyl transferase (GGT) in both T2DM patients, whereas there were significant elevations (p＜0.05) of alanine amino transferase (ALT) and alkaline phosphatase (ALP) in newly diagnosed and ALT (p＜0.001) and ALP (p＜0.01) in patients on treatment when compared with the control. There were significant (p＜0.001) differences in the levels of fasting plasma glucose (FPG) in both T2DM patients compared with the control. Prevalence of elevated ALT was 30.77%, ALP was 55.76% and GGT was 0% in patients on treatment; ALT was 32.0%, ALP was 56.0% and GGT was 4.0% in newly diagnosed patients compared with ALT of 0%, ALP of 30% and GGT of 0% in the control subjects. A positive correlation between ALT (r=0.265, p＜0.05), FPG (r=0.474, p＜0.01) and T2DM duration and between FPG and ALT (r=0.311, p＜0.01) and ALT andALP (r=0.234, p＜0.05) were observed in diabetic patients. Overall T2DM in both categories of patients predisposes to elevated levels of ALT and ALP but only ALT may be a useful biomarker for monitoring hepatic complication in T2DM without underlying hepatitis.
延伸閱讀
- Junaid, S. A., Agina, S. E., & Abubakar, K. A. (2014). Epidemiology and Associated Risk Factors of Hepatitis E Virus Infection in Plateau State, Nigeria. Virology: Research and Treatment, (2014), 15-26. https://doi.org/10.4137/VRT.S15422
- Akanni, E. O., Onuegbu, A. I., Adebayo, T. O., Eegunranti, B. A., & Oduola, T. (2013). Assessment of Some Selected Trace Metals in Chronic Myeloid Leukemia Patients in a Tertiary Health Facility in South West Nigeria. Asian Journal of Medical Sciences, 5(4), 71-75. https://www.airitilibrary.com/Article/Detail?DocID=20408773-201308-201510280023-201510280023-71-75
- Shiferaw, M. B., Tulu, K. T., Zegeye, A. M., & Wubante, A. A. (2016). Liver Enzymes Abnormalities among Highly Active Antiretroviral Therapy Experienced and HAART Naïve HIV-1 Infected Patients at Debre Tabor Hospital, North West Ethiopia: A Comparative Cross-Sectional Study. AIDS Research and Treatment, 2016(), 31-37. https://doi.org/10.1155/2016/1985452
- Ndako, J., Nwankiti, O., Okeke, C., Adekeye, A., Choji, T., Alesa, M., & Alarape, A. (2011). Screening Response to Hepatitis C Virus Antibodies among Diabetic Patients Attending UITH Nigeria. Current Research Journal of Biological Sciences, 3(6), 542-546. https://www.airitilibrary.com/Article/Detail?DocID=20410778-201111-201512280014-201512280014-542-546
- Osuji, C. U., Omejua, E. G., Onwubuya, E. I., & Ahaneku, G. I. (2012). Serum Lipid Profile of Newly Diagnosed Hypertensive Patients in Nnewi, South-East Nigeria. International Journal of Hypertension, 2012(), 613-619. https://doi.org/10.1155/2012/710486